Stock listing

Munich:BX20 BioXcel Therapeutics, Inc. Aktie

German listing (Munich) of BioXcel Therapeutics, Inc. · home listing NASDAQ:BTAI

Follow BioXcel Therapeutics, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:BTAI

$0.048 USD -0.002 (-3.3%)

Close on Oct 8, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BTAI · Data provided by Twelve Data

Past year -98.2% · daily closes, Oct 8, 2025 – Oct 8, 2026, adjusted for splits
Day range
$0.040 – $0.055 USDOct 8, 2026
Volume
70,578 sharesOct 8, 2026
52-week range
$0.019 – $2.870 USDLowest and highest trades, Oct 9, 2025 – Oct 8, 2026
BioXcel Therapeutics, Inc. logo
Ticker
Munich:BX20
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Munich
Currency
EUR

What changed lately

Calls

Replays

  • Bioxcel Therapeutics (NASDAQ:BTAI) Q3 2024 Earnings Call

    Thu, Nov 14, 2024 · 8:00 AM ET

    Watch Transcript
  • Bioxcel Therapeutics (NASDAQ:BTAI) Q2 2024 Earnings Call

    Tue, Aug 06, 2024 · 8:00 AM ET

    Watch Transcript
  • Bioxcel Therapeutics (NASDAQ:BTAI) Q1 2024 Earnings Call

    Thu, May 09, 2024 · 8:00 AM ET

    Watch Transcript

Latest news

All BioXcel Therapeutics, Inc. news

Decks

BioXcel Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
18 in the last 12 months · 174 in all · newest May 28, 2026 · oldest 2019
Calls
14 calls with a replay · 14 with a transcript · latest Nov 14, 2024
Decks
21 decks · latest November 2025

Where BioXcel Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BTAI · Home listingNASDAQUnited StatesUSD
BOATS:BTAIBOATSUnited StatesUSD
LS Exchange:A40YSRLS ExchangeGermanyEUR
gettex:BX20gettexGermanyEUR
Lang & Schwarz:A40YSRLang & SchwarzGermanyEUR
Tradegate:BX20TradegateGermanyEUR
Dusseldorf:BX20DusseldorfGermanyEUR
Frankfurt:BX20FrankfurtGermanyEUR
Hamburg:BX20HamburgGermanyEUR
Munich:BX20 · This pageMunichGermanyEUR
Stuttgart:BX20StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about BioXcel Therapeutics, Inc.